the need to identify new treatment strategies in cmml & the potential of targeting inflammation
Published 1 year ago • 460 plays • Length 2:03Download video MP4
Download video MP3
Similar videos
-
1:13
the unmet needs and future of cmml treatment
-
0:47
the potential of mdm2 inhibitors in the treatment of mpn
-
1:17
the curative potential of allosct in the treatment of hr-mds
-
1:04
the current standard of care for mds-related cytopenias and how treatment strategies may evolve
-
6:36
mds: low-risk disease treatment options
-
9:25
mgus diagnosis: a step-by-step approach
-
4:48
managing and treating mds
-
1:39
treating patients with myelofibrosis who are intolerant to or develop resistance to jak inhibitors
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
0:53
back to basics: the crucial role of cell membrane and gut health
-
0:47
novel agents being explored for the treatment of immune-mediated ttp
-
0:51
key unmet needs in the treatment of immune-mediated ttp
-
4:24
investigating production failure and out-of-specification production of car t-cell therapeutics
-
1:09
emerging treatment options for refractory immune thrombocytopenia
-
2:43
novel therapies in the future of mds treatment
-
1:30
advancements in prognostication tools in mpns in recent years
-
1:46
the efficacy of pacritinib in patients with myelofibrosis who have both thrombocytopenia and anemia
-
0:57
the potential of the tsafinder tool in hematological oncology
-
1:19
what's on the horizon for the treatment of mpns?
-
1:15
key unmet needs in t-cell lymphoma: developing novel therapeutic strategies to improve outcomes
-
1:22
managing cytopenias following jak inhibitor treatment & achieving true disease modification in mf